FASTURTEC Side Effects

6933900-9 | Bilirubin Conjugated Increased, Blood Bilirubin Increased, Cytolytic Hepatitis, Hepatic Steatosis, Jaundice
on Aug 18, 2010 Female patient from FRANCE , 73 years of age, weighting 294.1 lb, was diagnosed with hypothyroidism and was treated with Fasturtec (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin increased, cytolytic hepatitis, hepatic steatosis, jaundice (What is jaundice?). Fasturtec dosage: . During the same period patient was treated with ZAVEDOS (View Zavedos Review and Zavedos Label ), BELUSTINE (View Belustine Review and Belustine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), HYDREA (View Hydrea Review and Hydrea Label ), ZOPHREN (View Zophren Review and Zophren Label ), EMEND (View Emend Review and Emend Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6843698-0 | Haemolytic Anaemia, Thrombotic Thrombocytopenic Purpura
Patient was taking Fasturtec (View Usage). Patient had the following side effects: haemolytic anaemia, thrombotic thrombocytopenic purpura on Jul 12, 2010 from ITALY Additional patient health information: Male patient , 67 years of age, . Fasturtec dosage: . During the same period patient was treated with BENDAMUSTINE (View Bendamustine Review and Bendamustine Label ). Patient was hospitalized.

6731074-0 | Haemolytic Anaemia, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on May 14, 2010 by a Male patient taking Fasturtec (View Usage) (Dosage: ) . Location: ITALY , 67 years of age, After Fasturtec was administered, patient had the following side effects: haemolytic anaemia, thrombotic thrombocytopenic purpura. During the same period patient was treated with BENDAMUSTINE (View Bendamustine Review and Bendamustine Label ). Patient was hospitalized.

6677798-5 | Bone Infarction, Pain In Extremity
on Apr 08, 2010 Male patient from FRANCE , child 4 years of age, was treated with Fasturtec (View Usage). Patient experienced the following unwanted or unexpected effects: bone infarction, pain in extremity. Fasturtec dosage: . During the same period patient was treated with GLEEVEC (View Gleevec Review and Gleevec Label ), KARDEGIC (View Kardegic Review and Kardegic Label ).


6583486-6 | Grand Mal Convulsion, Loss Of Consciousness, Off Label Use, Urinary Incontinence
on Feb 12, 2010 Female patient from FRANCE , 86 years of age, was diagnosed with gouty arthritis and was treated with Fasturtec (View Usage). Patient had the following side effects: grand mal convulsion, loss of consciousness, off label use, urinary incontinence (What is urinary incontinence?). Fasturtec dosage: Dose:1.5 Milligram(s)/millilitre. Patient was hospitalized.

6583475-1 | Cardiac Failure, Off Label Use
Patient was taking Fasturtec (View Usage). After Fasturtec was administered, patient had the following side effects: cardiac failure, off label use on Feb 12, 2010 from FRANCE Additional patient health information: Female patient , 86 years of age, was diagnosed with gouty arthritis and. Fasturtec dosage: Dose:1.5 Milligram(s)/millilitre.

6055748-2 | Toxic Epidermal Necrolysis
Adverse event was reported on Jan 21, 2009 by a Female patient taking Fasturtec (View Usage) (Dosage: ) was diagnosed with hyperuricaemia, stem cell transplant, klebsiella infection, prophylaxis against transplant rejection and. Location: FRANCE , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. During the same period patient was treated with ANAFRANIL (Unk) (View Anafranil Review and Anafranil Label ), TERCIAN (Unk) (View Tercian Review and Tercian Label ), THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ), CIFLOX (Unk) (View Ciflox Review and Ciflox Label ), TAZOCILLINE (Unk) (View Tazocilline Review and Tazocilline Label ), METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ).

5244540-4 | Choreoathetosis, Mental Impairment
on Feb 12, 2007 Female patient from FRANCE , 82 years of age, weighting 99.21 lb, was treated with Fasturtec (View Usage). Patient had the following side effects: choreoathetosis, mental impairment. Fasturtec dosage: Unk. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), IRBESARTAN (Unk) (View Irbesartan Review and Irbesartan Label ), FORLAX (Unk) (View Forlax Review and Forlax Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), VALIUM (Unk) (View Valium Review and Valium Label ). Patient was hospitalized.

5219373-5 | Choreoathetosis, Mental Impairment
on Jan 15, 2007 Female patient from FRANCE , 82 years of age, weighting 99.21 lb, was treated with Fasturtec (View Usage). After Fasturtec was administered, patient had the following side effects: choreoathetosis, mental impairment. Fasturtec dosage: Unk. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), APROVEL (Unk) (View Aprovel Review and Aprovel Label ), FORLAX (Unk) (View Forlax Review and Forlax Label ), AMLOR (Unk) (View Amlor Review and Amlor Label ), VALIUM (Unk) (View Valium Review and Valium Label ). Patient was hospitalized.

4949241-5 | Thrombocytopenia
Patient was taking Fasturtec (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia on Mar 13, 2006 from FRANCE Additional patient health information: Male patient , 75 years of age, weighting 132.3 lb, . Fasturtec dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

4757607-1 | Agitation, Coma, Encephalopathy, Hyperammonaemia
Adverse event was reported on Aug 25, 2005 by a Female patient taking Fasturtec (View Usage) (Dosage: ) was diagnosed with tumour lysis syndrome, prophylaxis of nausea and vomiting and. Location: FRANCE , 72 years of age, Patient had the following side effects: agitation, coma, encephalopathy, hyperammonaemia. During the same period patient was treated with DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

4678069-9 | Injection Site Necrosis, Injection Site Vesicles
on May 18, 2005 Male patient from , 70 years of age, was diagnosed with non-hodgkin's lymphoma, infection (What is infection?) and was treated with Fasturtec (View Usage). After Fasturtec was administered, patient had the following side effects: injection site necrosis, injection site vesicles. Fasturtec dosage: Unk. During the same period patient was treated with GLUCOSE SOLUTION 30% (View Glucose Solution 30% Review and Glucose Solution 30% Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ), SODIUM CHLORIDE (Unk) (View Sodium Chloride Review and Sodium Chloride Label ), ANTIBIOTICS NOS (View Antibiotics Nos Review and Antibiotics Nos Label ). Patient was hospitalized.